Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$763M |
| 2 |
Amazon
AMZN
|
+$688M |
| 3 |
TSMC
TSM
|
+$562M |
| 4 |
Tesla
TSLA
|
+$419M |
| 5 |
Johnson & Johnson
JNJ
|
+$398M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
Novo Nordisk
NVO
|
+$366M |
| 4 |
JPMorgan Chase
JPM
|
+$335M |
| 5 |
ASML
ASML
|
+$325M |
Sector Composition
| 1 | Healthcare | 20.8% |
| 2 | Technology | 15.52% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Consumer Staples | 10.11% |
| 5 | Financials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
XBiotech
XBIT
$83.8M
| $356K | ﹤0.01% |
101,468
-54,000
| -35% | -$189K |
|
3152
Vital Energy
VTLE
$635M
| $355K | ﹤0.01% |
6,900
-113,330
| -94% | -$5.83M |
|
3153
Midland States Bancorp
MSBI
$385M
| $354K | ﹤0.01% |
13,300
+500
| +4% | +$13.3K |
|
3154
First Trust Nasdaq Oil & Gas ETF
FTXN
$117M
| $352K | ﹤0.01% |
+12,600
| New | +$352K |
|
3155
Standard BioTools
LAB
$493M
| $351K | ﹤0.01% |
300,100
-44,000
| -13% | -$51.5K |
|
3156
LCI Industries
LCII
$2.43B
| $351K | ﹤0.01% |
3,800
-55,400
| -94% | -$5.12M |
|
3157
SPDR Portfolio Long Term Treasury ETF
SPTL
$11.8B
| $351K | ﹤0.01% |
12,100
-107,300
| -90% | -$3.11M |
|
|
AFIB
3158
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $350K | ﹤0.01% |
304,500
-98,200
| -24% | -$113K |
|
|
AMYT
3159
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $350K | ﹤0.01% |
48,000
+300
| +0.6% | +$2.19K |
|
3160
Cheer Holding
CHR
$8.59M
| $349K | ﹤0.01% |
23,920
+20,742
| +653% | +$303K |
|
|
TRHC
3161
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $349K | ﹤0.01% |
70,600
-115,800
| -62% | -$572K |
|
3162
Core Laboratories
CLB
$581M
| $345K | ﹤0.01% |
+17,000
| New | +$345K |
|
3163
Federal Signal
FSS
$7.64B
| $344K | ﹤0.01% |
+7,402
| New | +$344K |
|
3164
iShares Global Financials ETF
IXG
$581M
| $344K | ﹤0.01% |
4,900
-400
| -8% | -$28.1K |
|
3165
Mid Penn Bancorp
MPB
$691M
| $344K | ﹤0.01% |
+11,469
| New | +$344K |
|
3166
New Fortress Energy
NFE
$373M
| $344K | ﹤0.01% |
8,100
-216,200
| -96% | -$9.18M |
|
3167
Invesco S&P 500 Pure Value ETF
RPV
$1.37B
| $343K | ﹤0.01% |
4,400
-7,500
| -63% | -$585K |
|
3168
Dine Brands
DIN
$368M
| $342K | ﹤0.01% |
+5,300
| New | +$342K |
|
3169
Zynex
ZYXI
$44.8M
| $342K | ﹤0.01% |
24,562
+7,200
| +41% | +$100K |
|
3170
ProShares Short High Yield
SJB
$69.1M
| $340K | ﹤0.01% |
17,900
-69,000
| -79% | -$1.31M |
|
3171
Outfront Media
OUT
$3.16B
| $338K | ﹤0.01% |
+20,726
| New | +$338K |
|
3172
SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.47B
| $337K | ﹤0.01% |
+5,200
| New | +$337K |
|
3173
GDS Holdings
GDS
$7.32B
| $336K | ﹤0.01% |
+16,300
| New | +$336K |
|
|
XYF
3174
X Financial
XYF
$579M
| $336K | ﹤0.01% |
111,175
-9,200
| -8% | -$27.8K |
|
|
YI
3175
111 Inc
YI
$51.3M
| $336K | ﹤0.01% |
11,135
| – | – |
|